SCHEMBL11074149

SCHEMBL11074149

CCc1c(-c2cccc(Br)c2)n[nH]c1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRNP P04156 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
PPARG P37231 1/20 0.45
HIF1A Q16665 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
NR2E3 Q9Y5X4 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
ALDH1A1 P00352 3/20 0.40
HSD17B10 Q99714 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
RAB9A P51151 5/20 0.40
NPC1 O15118 4/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.39
MAP2K4 P45985 1/20 0.39
MAPKAPK3 Q16644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070857 0.83 RXFP1 (0.46) PRNPCYP1A2CYP2C9CYP2C19PPARG
SCHEMBL11073722 0.81 PIN1 (0.46) ALDH1A1MAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL23294716 0.76 NPC1 (0.46) ALDH1A1HCAR2RAB9ANPC1MAPK1
SCHEMBL4678365 0.72 MAP2K4 (0.48) RAB9APOLBMAPK1MAP2K4MAPKAPK3
SCHEMBL11074145 0.71 RAB9A (0.48) CYP1A2NPSR1ALDH1A1RAB9ANPC1
SCHEMBL23329268 0.70 NPC1 (0.46) CYP1A2ALDH1A1HCAR2RAB9ANPC1
SCHEMBL4683639 0.69 GRK6 (0.45) ALDH1A1MAPK1MAPT
SCHEMBL25181131 0.69 GPR35 (0.44) HCAR2RAB9ANPC1MAPK1MAP2K4
SCHEMBL2493690 0.69 DHODH (0.75) AURKB
SCHEMBL23294535 0.68 BCL2 (0.51) HCAR2MAPK1MAP2K4MAPKAPK3MAPK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0112623-A2 3-Aryl-5-pyrazole-carboxylic-acid derivatives, their preparation and pharmaceutical compositions ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed